Mohammed Usman, MD
Hospitalist · Toms River, NJNPI 1265622195
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 45 manufacturers reported payments, led by Endologix LLC at 25.0% of the total. 2025 is the largest year on record at $18,136, more than ten times the $696 reported in 2019. Among hospitalist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 542 payments — averaging $60.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$8K
- Cagent Vascular Inc$7K
- Edwards Lifesciences$4K
- Abbott$3K
- Avinger Inc.$2K
- Boston Scientific$978
- plus $7K from 39 others
What the payments were for
- Consulting fees$8,80027%
- Travel & lodging$10,37032%
- Food & beverage$13,50441%
- Gifts$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Serrantor$7,200
- Torus Stent Graft System$6,155
- ENDOCROSS Device$6,155
- PANTHERIS$1,846
- TRICLIP$1,510
- EVOQUE$1,124
- SAPIEN 3 Ultra RESILIA$290
- AFX$284
- Ovation$232
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$182
- FARXIGA$173
- BRILINTA$173
- Confirm Rx$144
- CARDIOMEMS$128
- Quadra Assura CRT Defibrillator$114
- BioMimics 3D Vascular Stent System$108
- (5044) MCOT$105
- AVEIR$102
How this compares
$32,682 in reported general payments places this provider in the 95th percentile of 567 hospitalist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 13 | $313,573 |
| EliquisApixaban | 91 | $94,442 |
| XareltoRivaroxaban | 32 | $40,434 |
| EntrestoSacubitril/Valsartan | 33 | $40,336 |
| JardianceEmpagliflozin | 55 | $35,398 |
| BrilintaTicagrelor | 48 | $34,045 |
| Repatha SureclickEvolocumab | 30 | $33,154 |
| FarxigaDapagliflozin Propanediol | 23 | $19,014 |
| VerquvoVericiguat | 12 | $16,300 |
| NexletolBempedoic Acid | 11 | $5,034 |
| Ranolazine ErRanolazine | 41 | $2,501 |
| Amiodarone Hcl | 32 | $1,899 |
| ClopidogrelClopidogrel Bisulfate | 151 | $1,852 |
| Atorvastatin Calcium | 164 | $1,642 |
| Rosuvastatin Calcium | 113 | $1,616 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Eliquis | $180 | $408,016104 claims |
| AstraZenecaBrilinta, Farxiga | $835 | $53,05871 claims |
| Johnson & JohnsonXarelto | $577 | $40,43432 claims |
| NovartisEntresto | $670 | $40,33633 claims |
| Boehringer IngelheimJardiance | $277 | $35,39855 claims |
| MerckVerquvo | $363 | $16,30012 claims |
| Esperion Therapeutics, Inc.Nexletol | $86 | $5,03411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 567 hospitalist providers in New Jersey.
Other hospitalist in Toms River
- Justin BaptistAtlantic City$23K
- Jhonsua Jimenez AriasMorristown$15K
- Ahmed HassaninMorristown$15K
- Mohamed BakrAtlantic City$8K
- Jason NehmadNeptune$7K
- Rebecca ZweiflerMorristown$6K
- Scott KaufmanMount Holly$6K
- Kunal ParmarPompton Plains$6K
- Sameh GirgisNeptune$6K
- Arjun PatelCamden$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.